At this point, everyone involved in the industry feels that federal involvement is inevitable (if not long overdue)...the timing is what no one can pinpoint. IMO banking should have already happened...get these companies off of cash-only and onto a paper trail so that the govt can audit them and make sure that they are paying their fair share. The fact that the IRS is not the biggest advocate pushing the banking movement, honestly, has me scratching my head.
In general, it is hard not to become increasingly skeptical that anything will happen. I mean Florida, regardless of the amount of money that was recently invested in the push for adult use, seems like that excitement is waning by the day.
Personally, I could see banking happening...just don't know when...but I am struggling to wrap my head around the rescheduling piece. Sure we all know that it shouldn't be schedule 1 (there is medical value), however, the govt making (recent) moves within the research area has me thinking that this time around they will punt. They will reschedule the reschedule claiming that they want additional, DEA sponsored, medical research to support their decision...and then when that time comes they will decide that the best course of action is to deschedule the drug completely -- leaving the decision up to the states (bypassing the question of interstate commerce) and substitute the current 280E tax with a federal excise tax. Just my thoughts...so I'll guess 2026 before (non-banking) federal movement...and continue to hope that I am wrong and completely overshot it.
